Advertisement

Picture Fairtec GmbH Worldwide Event Solutions 600x60px

News > France & Monaco

Please find below news from France and Monaco as well as about organisations from these countries.

Total search results: 1464 | Ordered by Date (descending)
next pagenext page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Skuldtech. (9/11/13). "Press Release: Skuldtech Secures EUR 1 Million to Develop New Diagnostics for Alzheimer’s Disease. Skuldtech and AB Science to Renew Their Collaboration Agreement". Montpellier. 2013-09-11
bioMérieux S.A.. (9/3/13). "Press Release: bioMérieux Makes a Significant Acquisition in Molecular Biology in the U.S. – With the Acquisition of BioFire, bioMérieux Consolidates Its Postition as Major Player in Infectious Disease Diagnostics". Marcy l’Ét 2013-09-03
bioMérieux S.A.. (9/3/13). "Press Release: bioMérieux – First-half 2013 Results". Marcy l’Étoile. 2013-09-03
Diaxonhit S.A.. (9/3/13). "Press Release: Diaxonhit Signs a Research Service Agreement with Boehringer Ingelheim for the Discovery of Novel Epitope Targets". Paris. 2013-09-03
Sartorius AG. (9/3/13). "Press Release: Sartorius Stedim Biotech Signs Long-term Syndicated Loan. Credit Volume at 250 Million Euros – International Bank Syndicate Led by Commerzbank and Nord/LB". Aubagne & Goettingen. 2013-09-03
Novasep S.A.. (8/28/13). "Press Release: Novasep Appoints Christian Thiry as Chief Financial Officer". Pompey. 2013-08-28
bioMérieux S.A.. (8/21/13). "Press Release: bioMérieux Announces U.S. FDA Clearance for VITEK MS, a Revolutionary Technology which Reduces Microbial Identification from Days to Minutes Reinforcing Medical Value of Diagnostics". Marcy l’Étoile & Durham, N 2013-08-21
Valneva S.E.. (8/12/13). "Press Release: Valneva Announces Passing of Management Board Member, Chief Scientific Officer Majid Mehtali". Lyon. 2013-08-12
Sanofi S.A.. (8/1/13). "Press Release: Q2 2013 – Last Quarter with Significant Negative Impact from the Patent Cliff". Paris. 2013-08-01
Adocia S.A.. (7/29/13). "Press Release: Adocia Reacquires Exclusive Development Rights to Ultra-fast Acting Insulin Analog. Adocia and Lilly Terminate Collaboration". Lyon. 2013-07-29
Publicis Groupe S.A.. (7/28/13). "Press Release: Omnicom and Publicis Groupe to Merge. Merger of Equals to Create Publicis Omnicom Group, a Best-in-Class Communications, Advertising, Marketing and Digital Services Company". New York & Paris. 2013-07-28
AB Science S.A.. (7/24/13). "Press Release: AB Science and Its Partners Receive EUR 8.6 Million as Part of a Project Supported by Bpifrance in Alzheimer’s Disease". 2013-07-23
Sartorius AG. (7/23/13). "Press Release: Sartorius Stedim Biotech. Strong Growth Momentum in the First Half of 2013". 2013-07-23
bioMérieux S.A.. (7/18/13). "Press Release: First-half 2013 Business Review". Marcy l’Étoile. 2013-07-18
Valneva S.E.. (7/16/13). "Press Release: Valneva Announces a New EB66 Cell Line Research License Agreement with Boehringer Ingelheim". Lyon. 2013-07-16
Ipsen S.A.. (7/15/13). "Press Release: Ipsen Strengthens Its Neurology R&D Capabilities with the Acquisition of Syntaxin, a Leader in Recombinant Botulinum Toxin Technology". Paris. 2013-07-15
PathoQuest S.A.S.. (7/11/13). "Press Release: PathoQuest Raises EUR 3.8 Million in Series B Financing Round". Paris. 2013-07-11
Hybrigenics S.A.. (7/11/13). "Press Release: Hybrigenics First Half 2013 Revenues – Robust 12% Growth". Paris. 2013-07-11
ImaBiotech S.A.S.. (7/10/13). "Press Release: Servier and ImaBiotech Collaboration for the Implementation of a MALDI Imaging Platform Using Quantinetix Software". Lille. 2013-07-10
Deinove S.A.. (7/8/13). "Press Release: Deinove Appoints Nagib Ward as VP Business Development". Paris. 2013-07-08
Valneva S.E.. (7/4/13). "Press Release: Valneva Announces the Successful Completion of Its €40 Million Capital Increase – Transaction Was Oversubscribed by 146% [Not for US, Canada, Australia, or Japan]". Lyon. 2013-07-04
BioAlliance Pharma S.A.. (7/3/13). "Press Release: BioAlliance Pharma Receives €4.3 Million in Funding from bpifrance (ex OSEO) to Accelerate the Industrial Development of Livatag". Paris. 2013-07-03
Hybrigenics S.A.. (7/1/13). "Press Release: Hybrigenics Acquires Dualsystems Biotech’s Yeast Two-Hybrid (Y2H) Activities". Paris. 2013-07-01
BioAlliance Pharma S.A.. (6/28/13). "Press Release: BioAlliance Pharma Launches a Capital Increase of €8 Million with Maintenance of Preferential Subscription Rights to Accelerate the Development of the Two Major Orphan Products (Livatag and Validive) [N 2013-06-28
Temis. (6/27/13). "Press Release: Temis Acquires i3 Analytics". Paris & Columbia, MD. 2013-06-27
bioMérieux S.A.. (6/27/13). "Press Release: International Experts Join Forces against Suberbugs at the 4th World Forum on Healthcare-associated Infections and Antimicrobial Resistance. bioMérieux Commits to Supporting Expert-defined Global Priorities". M 2013-06-27
Novasep S.A.. (6/26/13). "Press Release: Michel Spagnol Appointed President and CEO of Novasep". Pompey. 2013-06-26
Genedata AG. (6/24/13). "Press Release: Genedata at ESACT Announces Expansion into Biopharma Process Development". Lille. 2013-06-24
bioMérieux S.A.. (6/20/13). "Press Release: bioMérieux Receives CE Marking for VIDAS 3, the New Generation of VIDAS". Marcy l’Étoile. 2013-06-20
Waters Corporation. (6/17/13). "Press Release: Waters Acquity UPC2 System Wins Green Innovation Prize". Amsterdam. 2013-06-17
PX’Therapeutics S.A.. (6/14/13). "Press Release: PX'Therapeutics Announces Appointment of New CEO". 2013-06-14
ImaBiotech S.A.S.. (6/10/13). "Press Release: Bruker and ImaBiotech Signed a Software Distribution Agreement to Promote and Distribute Quantinetix Software for Quantitative MALDI Imaging". Minneapolis, MN. 2013-06-10
bioMérieux S.A.. (5/30/13). "Press Release: bioMérieux Receives FDA Approval for THxID-BRAF Companion Diagnostic Test". Marcy l’Étoile. 2013-05-30
Cytoo S.A.. (5/24/13). "Press Release: Marc Le Bozec Joins Cytoo as Chief Executive Officer". Grenoble. 2013-05-24
bioMérieux S.A.. (5/21/13). "Press Release: Nicolas Cartier Appointed Corporate Vice President, Industrial Microbiology Unit of bioMérieux". Marcy l’Étoile. 2013-05-21
ElsaLys Biotech S.A.S.. (5/17/13). "Press Release: The Start-up ElsaLys Biotech, a New Player in the Therapeutic Monoclonal Antibody Arena, Announces the First Round of Financing with Transgene and Sofimac Partners". Lyon & Ilkirch-Graffenstaden. 2013-05-17
Cellectis S.A.. (4/29/13). "Press Release: Cellectis – 2012 Financial Results". Paris. 2013-04-29
Genticel S.A.. (4/24/13). "Press Release: Genticel Secures EUR 18.2 Million (USD 23.7 Million) in Capital Funding". Toulouse. 2013-04-24
Sartorius AG. (4/23/13). "Press Release: First-quarter Figures – SSB Group Continues on the Growth Track. Further Growth in Order Intake and Sales Revenue". Göttingen. 2013-04-23
bioMérieux S.A.. (4/23/13). "Press Release: bioMérieux – First-quarter 2013 Business Review". Marcy l’Étoile. 2013-04-23
Diaxonhit S.A.. (4/23/13). "Press Release: Diaxonhit Wins a Major Public Tender from the Paris Hospitals (Assistance Publique Hôpitaux de Paris)". Paris. 2013-04-23
Theradiag S.A.. (4/23/13). "Press Release: Theradiag Receives 3rd CE Mark Approval for New anti-CCP In-vitro Diagnostic Kit in Rheumatoid Arthritis". Croissy-Beaubourg. 2013-04-23
Theradiag S.A.. (4/16/13). "Press Release: Revenues and Financial Results for 2012 in Line with Expectations". Croissy-Beaubourg. 2013-04-16
IntegraGen S.A.. (4/15/13). "Press Release: IntegraGen Reports Annual Results for 2012". Evry. 2013-04-15
Genfit S.A.. (4/15/13). "Press Release: Genfit Successfully Raises More than 14M€ Increasing Its Cash Position to 30M€ [Not for USA, Canada, Japan or Australia]". Lille. 2013-04-15
Angany Genetics. (4/12/13). "Press Release: Angany Genetics Announces the Launch of Its New Production Unit and Gears Up for Supply of Its First Allergens for the Treatment of Dust-mite and Pollens Allergies as from September 2013". Val-de-Reuil. 2013-04-12
EyeBrain. (4/11/13). "Press Release: EyeBrain Launches an International Clinical Trial of Its Application for Dyslexia. EUR 220,000 of Backing from the EUREKA-Eurostars Program". Ivry-sur-Seine. 2013-04-11
Eyevensys. (4/11/13). "Press Release: Eyevensys Announces an Equity Investment by Boehringer Ingelheim Venture Fund". Paris. 2013-04-11
Theradiag S.A.. (4/9/13). "Press Release: Theradiag Granted 1.2 Million Euros by OSEO as Part of the Collaborative Project CaReNA". Croissy-Beaubourg. 2013-04-09
Temis. (4/9/13). "Press Release: Wiley Selects Temis for Semantic Big Data Initiative". Hoboken, NJ & New York, NY. 2013-04-09
GenSight Biologics S.A.. (4/8/13). "Press Release: GenSight Biologics Raises €32m in a Series A Financing for Ophthalmic Gene Therapy". Paris. 2013-04-08
Vivalis S.A.. (4/8/13). "Press Release: Vivalis Announces a New EB66 Cell Line Research Services and License Option Agreement with GlaxoSmithKline". 2013-04-08
Neovacs S.A.. (3/29/13). "Press Release: Financial Results for 2012". Paris. 2013-03-29
Hybrigenics S.A.. (3/28/13). "Press Release: Hybrigenics 2012 Full Year Results". Paris. 2013-03-28
Stentys S.A.. (3/28/13). "Press Release: Stentys Reports 2012 Financial Results". Princeton, N.J. & Paris. 2013-03-28
Diaxonhit S.A.. (3/26/13). "Press Release: Diaxonhit Reports 2012 Results". Paris. 2013-03-26
Analytik Jena AG. (3/26/13). "Press Release: Formal Inauguration of Newly Formed Subsidiary in France". Jena & Savigny-le-Temple. 2013-03-26
Oncodesign S.A.. (3/26/13). "Press Release: Oncodesign Signs a Partnership Agreement and an Option for Exclusive Licensing with Sanofi in the Area of Tissue Protection and Repair". Dijon. 2013-03-26
Vivalis S.A.. (3/26/13). "Press Release: The Expanded Development of EB66 Cell Line as Part of the GlaxoSmithKline (GSK) – Texas A&M University System Influenza Vaccine Program in the United States". Nantes & Lyon. 2013-03-26
Vivalis S.A.. (3/26/13). "Press Release: Consolidated 2012 Financial Results". Nantes & Lyon. 2013-03-26
Eyevensys. (3/25/13). "Press Release: Eyevensys Appoints Dr Ivan Cohen-Tanugi as CEO". Paris. 2013-03-25
bioMérieux S.A.. (3/25/13). "Press Release: Veolia Environnement and bioMérieux Initiate a Resarch Partnership to Develop an Innovative Monitoring System for Drinking Water Quality". Paris & Lyon. 2013-03-25
Cytoo S.A.. (3/18/13). "Press Release: Olivier Pasquier Joins Cytoo as Chief Commercial Officer". Grenoble. 2013-03-18
Leco Corporation. (3/13/13). "Press Release: European GCxGC Symposium Scheduled for September". St. Joseph, MI. 2013-03-13
bioMérieux S.A.. (3/13/13). "Press Release: 2012 Financial Results". Marcy l’Étoile. 2013-03-13
Neovacs S.A.. (3/12/13). "Press Release: Success of the Neovacs Capital Increase. Offering Oversubscribed by 35% – €7.2 Million Raised after Full Implementation of Extension Clause [Not for release to United States of America, Canada, Australia, Italy or 2013-03-12
EyeTechCare S.A.. (3/12/13). "Press Release: EyeTechCare Raises EUR Ten Million in a Third Round of Funding". Rillieux-la-Pape. 2013-03-12
Oncodesign S.A.. (3/11/13). "Press Release: Oncodesign and OSEO, Winners of the IMODI Project from the French Government’s Investing for the Future Program, Announce Funding of EUR 13.4 Million". Dijon & Paris. 2013-03-11
Cellectis S.A.. (3/7/13). "Press Release: Cellectis and Stemgent Parter to Provide Custom Genome-engineered iPS Cells". Cambridge, MA. 2013-03-07
Vivalis S.A.. (3/7/13). "Press Release: Vivalis SA and Intercell AG Shareholders Approved the Proposed Merger of Equals to Create Valneva SE". Nantes & Vienna. 2013-03-07
Diaxonhit S.A.. (2/28/13). "Press Release: Diaxonhit Solidifies Its Position as a Major Player in the Field of Transplantation. Award by the French Blood Bank of Four National Public Tenders to Its Marketing Subsidiary InGen". Paris. 2013-02-28
Ipsen S.A.. (2/27/13). "Press Release: Christel Bories Joins Ipsen as Deputy Chief Executive Officer". Paris. 2013-02-27
Ipsen S.A.. (2/27/13). "Press Release: Ipsen’s 2012 Results and 2013 Financial Objectives". Paris. 2013-02-27
Ipsen S.A.. (2/27/13). "Press Release: Ipsen 2012 Financial Results. Full Year 2012 Results Presentation". Paris. 2013-02-27
Cellectis S.A.. (2/25/13). "Press Release: Cellectis Announces Appointment of Pierre Schwich as Group CFO". Paris. 2013-02-25
Neovacs S.A.. (2/15/13). "Press Release: Neovacs Launches €6.3 Million Capital Increase to Finance Clinical Proof-of-Concept for the TNF-Kinoid [Not for USA, Canada, Australia, Italy or Japan]". Paris. 2013-02-15
Theradiag S.A.. (2/15/13). "Press Release: Theradiag Receives CE Mark Approval for Two New Lisa Tracker Monitoring Kits in Theranostics". Croissy-Beaubourg. 2013-02-15
Analytical Pixels Technology S.A.S. (APIX). (2/14/13). "Press Release: APIX Technology Introduces Industry’s First Gas Chromatography Device Based on Silicon Nano-scale Components". Grenoble. 2013-02-14
Vivalis S.A.. (2/14/13). "Press Release: 2012 – A Record Year for New EB66 Cell Line Licensing". Nantes. 2013-02-14
Analytical Pixels Technology S.A.S. (APIX). (2/7/13). "Press Release: APIX Technology Signs a Comprehensive IP Licensing Agreement with CEA-Leti and Caltech. APIX Secures Rights to Industry Leading Nano-scale Sensor Technology". Grenoble. 2013-02-07
Diaxonhit S.A.. (2/6/13). "Press Release: Diaxonhit Is Informed by Allergan that Bristol-Myers Squibb Has Decided to Stop Development of EHT/AGN 001". Paris. 2013-02-06
Clevexel Pharma. (2/1/13). "Press Release: Clevexel Pharma, a Recently Formed Spin-off from Teva, Presents Its Management Team, Strategic Positioning and Mid-term Objectives". Maisons-Alfort, Paris. 2013-02-01
Deinove S.A.. (1/9/13). "Press Release: Emmanuel Petiot Becomes CEO of Deinove. Emmanuel Petiot Was formerly Director of Sales of Novozymes in the United States". Paris. 2013-01-09
Alizé Pharma. (1/3/13). "Press Release: Alizé Pharma Launches the PREMAG Research Program". Lyon. 2013-01-03
Eurofins Scientific. (1/2/13). "Press Release: Eurofins Subsidiary Agrees to Acquire a Further 7% Additional Stake in Cerep S.A.". 2013-01-02
Cellectis S.A.. (12/18/12). "Press Release: Cellectis – an Innovative Anti-cancer Approach. The University College of London and Cellectis Have Signed a Collaboration Agreement to Develop a T-cell Adoptive Immunotherapy to Fight Leukemia". Paris. 2012-12-18
Poxel S.A.. (12/18/12). "Press Release: Poxel Raises €13 Million to Progress Imeglimin Development to Treat Type 2 Diabetes". Lyon. 2012-12-18
Oncodesign S.A.. (12/18/12). "Press Release: Oncodesign and the Laboratory for Neurobiology and Gene Therapy at the KU Leuven Enter into a Research Collaboration for Advancing Drug Discovery Efforts with Ipsen in Parkinson’s Disease". Dijon, Leuven & Par 2012-12-18
Vivalis S.A.. (12/16/12). "Press Release: Proposed Merger of Equals between Vivalis and Intercell. Creation of a European Biotech Leader in Vaccines and Antibodies [Not for Distribution in Australia, Canada, Japan or the United States]". Nantes & Vienna. 2012-12-16
Institut Curie. (12/12/12). "Press Release: Curie-Cancer Funds Its First Selection of 5 Late-stage Projects". Paris. 2012-12-12
Theradiag S.A.. (12/6/12). "Press Release: Success of the Theradiag IPO. €8.2 Million Raised [Not for direct or indirect distribution in the United States, Canada, Australia, Italy or Japan]". Croissy-Beaubourg. 2012-12-06
bioMérieux S.A.. (12/4/12). "Press Release: bioMérieux Opens a Subsidiary in Vietnam, Strengthening Its Footprint in High-growth Southeast Asia". Marcy l’Étoile. 2012-12-04
Advanced Chemistry Development, Inc. (ACD/Labs). (12/3/12). "Press Release: Increasing the Efficiency of Complex By-products Research with ACD/Structure Elucidator". Toronto. 2012-12-03
Ipsogen S.A.. (11/29/12). "Press Release: Ipsogen to Be Renamed Qiagen Marseille on the First of January 2013. Results of the General Assembly of 14 November 2012 – Perspectives for 2013". Marseille. 2012-11-29
Evotec AG. (11/23/12). "Press Release: Evotec Receives CIR (French Research Tax Credit) Accreditation". Hamburg. 2012-11-23
ObeTherapy Biotechnology. (11/22/12). "Press Release: ObeTherapy Announces the Publication of Results Obtained with One of its Lead Compounds on a New Target for the Treatment of Obesity and Type II Diabetes". Paris. 2012-11-22
bioMérieux S.A.. (11/15/12). "Press Release: bioMérieux and Quanterix Sign Strategic Partnership in Ultrasensitive and Multiplex Immunoassays. Quanterix’s Simoa Technology to Be Developed for Diagnostic Applications". Marcy l’Étoile & Lexington, MA. 2012-11-15
Exonhit S.A.. (11/6/12). "Press Release: Exonhit Announces the Upcoming Acquistion of InGen BioSciences, the Leading Independent Distributor of In-vitro Diagnostics in the French Market [Not for distribution in the U.S., Japan, Canada and Australia]". Pa 2012-11-06
Poxel S.A.. (11/5/12). "Press Release: Poxel’s Anti-diabetic Imeglimin Shows Significant Clinical Benefits in Type 2 Diabetes when Added to Sitagliptin. Phase II Study Achieved Primary and Secondary Endpoints". Lyon. 2012-11-05
Ipsen S.A.. (10/29/12). "Press Release: Ipsen’s Third Quarter and First Nine Months 2012 Sales". Paris. 2012-10-29
next pagenext page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15  next pagenext page



Advertisement

Picture Fairtec GmbH Worldwide Event Solutions 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

» top